Cannabidiol (CBD) is one of the most well-researched compounds derived from the cannabis plant, celebrated for its therapeutic potential without causing intoxication. Unlike THC, CBD does not produce a psychoactive “high.” Instead, it interacts with the body’s endocannabinoid system (ECS) to regulate key functions such as mood, pain, inflammation, and sleep (Simei et al., 2024).

Evidence: Unlike THC, CBD does not cause a “high” but interacts with the endocannabinoid system to regulate mood, pain, and inflammation (Simei et al., 2024).

The ECS (endocannabinoid system) is critical in maintaining homeostasis, or balance, within the body. CBD interacts with ECS receptors (CB1 and CB2) to influence immune response, nervous system activity, and hormonal balance (Simei et al., 2024). This makes CBD a versatile compound with a wide range of applications, from reducing anxiety to managing chronic pain.

Evidence: Research suggests CBD modulates the immune response, nervous system activity, and hormonal balance, making it beneficial for stress, pain relief, and overall well-being (Millar et al., 2019).

Research suggests that CBD may help reduce inflammation and muscle damage associated with physical exertion, potentially aiding recovery (Rojas-Valverde, 2021).

Evidence: Studies indicate that CBD supports muscle recovery and pain relief in athletes (Rojas-Valverde, 2021).

Topicals (creams, balms): Applied directly to the skin to target specific areas of discomfort.

Oral products (oils, capsules): Ingested to provide systemic effects.

There is evidence suggesting that CBD may help with both falling asleep and staying asleep, in part by addressing chronic pain and anxiety (Shannon et al., 2019).

Evidence: Studies have confirmed that CBD improves sleep in people with anxiety and insomnia (Shannon et al., 2019).

CBD is generally well-tolerated but may cause dry mouth, drowsiness, and appetite changes (Iffland & Grotenhermen, 2017).

Evidence: Potential side effects include fatigue and medication interactions (Iffland & Grotenhermen, 2017).

Some studies indicate that CBD may help reduce pain and inflammation (Vučković et al., 2018).

Evidence: Clinical trials have demonstrated CBD’s effectiveness in managing arthritis pain and neuropathic pain (Vučković et al., 2018).

It is recommended to start with a low dose and monitor your body's response. Consult with a healthcare professional before incorporating CBD into your routine, especially if you have underlying health conditions or are taking other medications.

In 2019, the World Anti-Doping Agency (WADA) removed CBD from its list of prohibited substances. However, THC and other cannabinoids are still prohibited. It is best to check with the sport's governing body to ensure compliance.

To comply with regulations, athletes should ensure they use third-party tested products and are free from THC (World Anti-Doping Agency, 2025).

While research on CBD’s potential benefits is promising, more high-quality studies are needed to fully understand its efficacy and safety (Iffland & Grotenhermen, 2017).

Evidence: A review published in Frontiers in Neurology found that CBD may help improve quality of life in patients with neurological disorders, though long-term data is still required (Nicholson et al., 2020).

Research suggests that CBD exhibits anti-inflammatory, analgesic, and neuroprotective properties, which could be beneficial in treating conditions such as chronic pain, epilepsy, and anxiety disorders (Blessing et al., 2015; Vučković et al., 2018).

A 2019 report from the World Health Organization (WHO) concluded that CBD is generally safe, well-tolerated, and non-addictive, though they called for further controlled studies to confirm therapeutic potential (WHO, 2018).

Preclinical studies indicate that CBD reduces oxidative stress and neuroinflammation, which may have implications for neurodegenerative diseases such as Alzheimer’s and Parkinson’s (Esposito et al., 2011).

Although some clinical trials show CBD’s positive impact on anxiety, pain, and sleep, researchers emphasize the need for larger randomized controlled trials to establish consistent dosing guidelines and long-term safety data (Shannon et al., 2019).